Management Team
Adriaan Aarts
Adriaan (born in 1965) studied Economics at Tilburg University and began his career in banking. After spending two years at Citigroup in Zurich and Paris, he joined ABN AMRO, where…
Rob Collin, PhD
“Due to their high specificity, antisense oligonucleotides hold great promise to correct RNA defects underlying many inherited diseases”
Melita Kaltak, PhD
"I'm committed to helping develop solutions for individuals with vision disorders. My goal is to advance antisense oligonucleotides from research to clinical trials, making a difference in the lives of the community affected by Stargardt disease and Usher syndrome."
Research Team
Alice Randon
Alice (born in 1999) holds a Master’s degree in pharmaceutical biotechnology from the University of Milan. After graduation, she joined the National Insitute of Molecular Genetics (INGM) in Milan as a…
Erwin van Wijk, PhD
"Being able to save vision will be a life-changing event for people with a blinding disorder"
Femke Bukkems
"By researching treatment for retinal disorders, I hope to help and eventually cure patients with these diseases so that they can once again enjoy all that is happening around them."
Drug Development Team
Bianca Matthee
Bianca Matthee, PharmD, MSc in Pharmaceutical Sciences from Utrecht University, brings over 17 years of expertise in Life Sciences. As the founder of BMPharm, she advises and fills interim management…
Cathaline den Besten, PhD
Cathaline den Besten is a seasoned nonclinical expert with over 30 years of experience in translational drug development, toxicology and DMPK. She has gained wide-ranging R&D experience from early research…
Clinical Operations Team
Carel Hoyng, MD, PhD
“My ultimate goal is to find a cure for inherited retinal diseases”
General Advisory Board
Markwin Velders
Dr. Markwin Velders obtained his PhD in molecular immunology at the Leiden University and worked as scientist and assistant professor at Loyola University Chicago, authoring over 40 peer reviewed papers…
Maarten Scholten
After obtaining his law degree at the University of Amsterdam (The Netherlands), Mr. Scholten started his career as an attorney at the Amsterdam and New York offices of Loeff &…
Lucy Peltenburg, PhD
After obtaining her PhD in molecular biology of cancer at the University of Leiden, Dr. Lucy Peltenburg worked as a post-doc at the Biology department at the University of California…
Clinical Advisory Board
Camiel J.F. Boon, MD, PhD
Camiel Boon, MD, PhD, FEBO, is a Consultant Ophthalmologist at Amsterdam University Medical Centers and at Leiden University Medical Center (the Netherlands). Already at the age of 36, he was…